224 related articles for article (PubMed ID: 4879373)
1. Use of anticancer drugs during pregnancy.
Stutzman L; Sokal JE
Clin Obstet Gynecol; 1968 Jun; 11(2):416-27. PubMed ID: 4879373
[No Abstract] [Full Text] [Related]
2. Teratogenicity from drugs--an increasing problem.
Shepard TH
Dis Mon; 1974 Jun; ():1-32. PubMed ID: 4494537
[No Abstract] [Full Text] [Related]
3. [Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].
Schmähl D
Internist (Berl); 1971; 12():Suppl 1:115-9. PubMed ID: 5002614
[No Abstract] [Full Text] [Related]
4. [Hepatotoxicity of antimitotic treatments. Effect of hepatic tests].
Robert J; Barbier P; Manaster J; Jacobs E
Rev Int Hepatol; 1968; 18(3):427-44. PubMed ID: 5685733
[No Abstract] [Full Text] [Related]
5. [Cytostatic therapy causing the loss of serological activity in thrombocytes].
Májský A; Jakoubková J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(4):425-34. PubMed ID: 4195491
[No Abstract] [Full Text] [Related]
6. [Fetal risk of cancer chemotherapy (author's transl)].
Schaison G; Jacquillat C; Auclerc G; Weil M
Bull Cancer; 1979; 66(2):165-70. PubMed ID: 465749
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in the carcinogenicity of anticancer agents.
Prejean JD; Montgomery JA
Drug Metab Rev; 1984; 15(3):619-46. PubMed ID: 6386411
[No Abstract] [Full Text] [Related]
8. The use of cytotoxic drugs in the surgery of malignant disease.
Watt J
J Bone Joint Surg Br; 1968 Aug; 50(3):511-23. PubMed ID: 4303179
[No Abstract] [Full Text] [Related]
9. [Pharmacological basis of antineoplastic therapy].
Salva JA
ADM; 1969; 26(6):609-19. PubMed ID: 4189089
[No Abstract] [Full Text] [Related]
10. [Progress in the diagnosis and therapy of trophoblastic tumors].
Onnis A
Attual Ostet Ginecol; 1967; 12(4):251-89. PubMed ID: 4298892
[No Abstract] [Full Text] [Related]
11. [CYTOSTATIC THERAPY].
LOPESCARDOZO E
Geneeskd Bl; 1964; 51():1-70. PubMed ID: 14140048
[No Abstract] [Full Text] [Related]
12. [Hair changes in immunosuppressive therapy].
Kostanecki W; Mazurkiewicz W; Górkiewicz A; Zborzil J
Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252
[No Abstract] [Full Text] [Related]
13. Cancer chemotherapy. 3.
Greenwald ES
N Y State J Med; 1972 Nov; 72(22):2757-68. PubMed ID: 4571816
[No Abstract] [Full Text] [Related]
14. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Schein PS; Winokur SH
Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
[TBL] [Abstract][Full Text] [Related]
15. [The cancerogenicity of antineoplastic agents].
Rieche K
Arch Geschwulstforsch; 1969; 34(2):240-54. PubMed ID: 4920118
[No Abstract] [Full Text] [Related]
16. [Detection of a moderate staphylococcal phage by means of antineoplastic agents].
Smolianskaia AZ; Leĭkina FI
Antibiotiki; 1970 Jun; 15(6):514-9. PubMed ID: 4195833
[No Abstract] [Full Text] [Related]
17. [Carcinogenicity of anticancer agents].
Hayashi Y; Takahashi M; Yoshimura H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2293-8. PubMed ID: 2260866
[TBL] [Abstract][Full Text] [Related]
18. Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Levantine A; Almeyda J
Br J Dermatol; 1974 Feb; 90(2):239-42. PubMed ID: 4132051
[No Abstract] [Full Text] [Related]
19. [Possible applications of antivitamins and antimetabolites in therapy].
Frick PG
Bibl Nutr Dieta; 1966; 8():6-16. PubMed ID: 5950495
[No Abstract] [Full Text] [Related]
20. [REPERCUSSIONS OF NEUROLEPTIC AND ANTITUMOR AGENTS ON PRENATAL DEVELOPMENT].
TUCHMANN-DUPLESSIS H; MERCIER-PAROT L
Bull Schweiz Akad Med Wiss; 1964 Sep; 20():490-526. PubMed ID: 14192394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
